1 min read •
Biotech companies are back on the Stock Exchange market
Biotech companies have hardly suffered from the economic crisis. They are again on the stock market. Pharmaceutical laboratories have benefited from multiple partnerships and buyouts: thanks to this strategy, biotech companies successfully obtain financing.
Biotech companies have hardly suffered from the economic crisis. They are again on the stock market. Pharmaceutical laboratories have benefited from multiple partnerships and buyouts: thanks to this strategy, biotech companies successfully obtain financing.
RELATED INFORMATION
Arthur D. Little expands Healthcare & Life Sciences Practice in Germany and Switzerland with leading biotech expertise
Dr. Franziska Thomas appointed as Associate Director to lead the way for innovative technology in the pharmaceutical and biotech sectors Global Management Consultancy Arthur D. Little (ADL), today…
Launch excellence for new medicines
After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises and the number of New Molecular Entities (NMEs) approved by the US FDA…
Coming Together -Success Through Clustering
The concept of clusters promises to be a winning solution for regions wanting a slice of the cake in new technological fields. In the textbook it all seems very simple. Take a region, throw in…